Patents by Inventor Mark Geisberg

Mark Geisberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Detection of Antibiotic-Resistant Bacteria
    Publication number: 20180156796
    Abstract: The invention relates to novel methods of diagnosis of the presence of antibiotic-resistant bacteria in a liquid or solid sample, detection of antibiotic-resistant bacterial infections in humans or animals, and the use of antibodies or other specific binding molecules capable of binding to products of reactions carried out by bacterial enzymes which confer antibiotic resistance upon bacteria.
    Type: Application
    Filed: December 1, 2017
    Publication date: June 7, 2018
    Applicant: Silver Lake Research Corporation
    Inventor: Mark Geisberg
  • Biomarkers for detecting the presence of bacteria
    Patent number: 9052314
    Abstract: In some aspects, provided are methods relating to the use of bacterial N-methyl-2 superfamily proteins as a biomarker for the presence of bacteria in a sample. The invention also relates to novel methods of diagnosis of the presence of bacteria in a liquid or solid sample, detection of bacterial infections in humans or animals, and use of antibodies or other specific binding molecules capable of binding to N-methyl-2 superfamily proteins.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: June 9, 2015
    Assignee: SILVER LAKE RESEARCH CORPORATION
    Inventors: Robert K. DiNello, Mark Geisberg
  • BIOMARKERS FOR DETECTING THE PRESENCE OF BACTERIA
    Publication number: 20140273022
    Abstract: In some aspects, provided are methods relating to the use of bacterial N-methyl-2 superfamily proteins as a biomarker for the presence of bacteria in a sample. The invention also relates to novel methods of diagnosis of the presence of bacteria in a liquid or solid sample, detection of bacterial infections in humans or animals, and use of antibodies or other specific binding molecules capable of binding to N-methyl-2 superfamily proteins.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Inventors: Robert K. DiNello, Mark Geisberg